Medicaid drug costs are much lower than Medicare Part D costs, report finds
Aug 17, 2011
Medicaid’s net unit drug costs are much lower than costs under Medicare Part D, which is attributed to higher Medicaid rebates for brand name medications, according to a new report.
McCain spokesman denies Obama’s Medicare claims
Oct 21, 2008
Sen. Barack Obama (D) recently accused his rival in the presidential race of planning to slice $882 billion from Medicare to fund his healthcare plan. It is a charge Sen. John McCain’s (R) camp refutes.
Obama budget calls for Medicare cuts for SNFs, penalizes rehospitalizations
Feb 14, 2012
While President Obama’s proposed 2013 budget contains expected Medicare cuts, long-term care groups have expressed their disappointment. Among other proposals, the American Health Care Association...
Congress asks GAO to investigate Medicare and Medicaid antifraud contractors
Jun 27, 2012
Following a series of troubling reports about the success rate of antifraud contractors, lawmakers are asking the Government Accountability Office to study Medicare and Medicaid audit programs.
Advocacy groups plead for end to two-year wait for Medicare coverage for disabled
Nov 14, 2008
Healthcare and disability advocacy groups have launched a campaign to end the two-year waiting period the disabled must endure before qualifying for Medicare.
Medicare costs could soar with availability of new obesity drugs, experts say
By
Alicia Lasek
Mar 15, 2023
If efforts are successful to expand Medicare Part D to cover these drugs, premiums could soar, according to economists with Vanderbilt University and the University of Chicago.
Medicare eligibility comes with increase in tooth loss, Harvard study reveals
By
Alicia Lasek
Feb 10, 2023
When patients become eligible for Medicare coverage, restorative dental care immediately falls and tooth loss increases, a new study from Harvard University and Brigham and Women’s Hospital has found.
Stuck in the middle, LTC pharmacies could be dangerously squeezed by drug price negotiations
By
Kimberly Marselas
Sep 01, 2023
Any lower drug prices that result from White House efforts to negotiate on behalf of Medicare beneficiaries may lead to short-term gains for nursing homes, but there also could be a steep price to pay...